RSS 1.0
Sydney Pharmacy School
Browse by
Recent Submissions
-
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
Published 2022Combination tetrahydrocannabinol (THC)/cannabidiol (CBD) medicines or CBD-only medicines are prospective treatments for chronic pain, stress, anxiety, depression, and insomnia. THC and CBD increase signaling from cannabinoid ...Open AccessArticle -
Enhancing Endocannabinoid Control of Stress with Cannabidiol.
Published 2021The stress response is a well-defined physiological function activated frequently by life events. However, sometimes the stress response can be inappropriate, excessive, or prolonged; in which case, it can hinder rather ...Open AccessArticle -
The intestinal microbiota and improving the efficacy of COVID-19 vaccinations
Published 2021Most COVID-19 cases are mild or asymptomatic and recover well, suggesting that effective immune responses ensue, which successfully eliminate SARS-CoV-2 viruses. However, a small proportion of patients develop severe ...Open AccessArticle -
Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis.
Published 2022Non-alcoholic fatty liver disease (NAFLD) progresses from simple steatosis to steatohepatitis (NASH), which may then progress to the development of cirrhosis and hepatocarcinoma. NASH is characterized by both steatosis and ...Open AccessArticle -
Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences.
Published 2022The recent article by Nielsen and colleagues [1] presents an interesting cross-sectional investigation on a subgroup of cancer patients that self-prescribed cannabinoids. The authors present a study with a high response ...Open AccessArticle, Letter